BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12953153)

  • 1. [Pathogenesis of diabetic macular oedema].
    Krohne TU; Fauser S; Kirchhof B; Joussen AM
    Klin Monbl Augenheilkd; 2003 Aug; 220(8):521-5. PubMed ID: 12953153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.
    Klaassen I; Van Noorden CJ; Schlingemann RO
    Prog Retin Eye Res; 2013 May; 34():19-48. PubMed ID: 23416119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process.
    Ehrlich R; Harris A; Ciulla TA; Kheradiya N; Winston DM; Wirostko B
    Acta Ophthalmol; 2010 May; 88(3):279-91. PubMed ID: 20222885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema.
    Vinten M; Larsen M; Lund-Andersen H; Sander B; La Cour M
    Acta Ophthalmol Scand; 2007 Feb; 85(1):21-6. PubMed ID: 17244205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of vascular permeability in diabetic retinopathy.
    Antonetti DA; Lieth E; Barber AJ; Gardner TW
    Semin Ophthalmol; 1999 Dec; 14(4):240-8. PubMed ID: 10758225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
    Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
    Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier.
    Sander B; Larsen M; Moldow B; Lund-Andersen H
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):433-8. PubMed ID: 11157879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of diabetic macular edema.
    Joussen AM; Smyth N; Niessen C
    Dev Ophthalmol; 2007; 39():1-12. PubMed ID: 17245075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of macular edema.
    Scholl S; Kirchhof J; Augustin AJ
    Ophthalmologica; 2010; 224 Suppl 1():8-15. PubMed ID: 20714176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.
    Sander B; Thornit DN; Colmorn L; Strøm C; Girach A; Hubbard LD; Lund-Andersen H; Larsen M
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3983-7. PubMed ID: 17724176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography: a key to the future management of patients with diabetic macular oedema.
    Massin P; Girach A; Erginay A; Gaudric A
    Acta Ophthalmol Scand; 2006 Aug; 84(4):466-74. PubMed ID: 16879566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of endothelial junctional permeability.
    Vandenbroucke E; Mehta D; Minshall R; Malik AB
    Ann N Y Acad Sci; 2008 Mar; 1123():134-45. PubMed ID: 18375586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy.
    Felinski EA; Antonetti DA
    Curr Eye Res; 2005 Nov; 30(11):949-57. PubMed ID: 16282129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.
    Navaratna D; McGuire PG; Menicucci G; Das A
    Diabetes; 2007 Sep; 56(9):2380-7. PubMed ID: 17536065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macular edema. General pathophysiology.
    Augustin A; Loewenstein A; Kuppermann BD
    Dev Ophthalmol; 2010; 47():10-26. PubMed ID: 20703041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization.
    Vinores SA; Küchle M; Derevjanik NL; Henderer JD; Mahlow J; Green WR; Campochiaro PA
    Histol Histopathol; 1995 Oct; 10(4):913-23. PubMed ID: 8574012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic correlation of angiography and high-resolution optical coherence tomography in diabetic macular edema.
    Bolz M; Ritter M; Schneider M; Simader C; Scholda C; Schmidt-Erfurth U
    Ophthalmology; 2009 Jan; 116(1):66-72. PubMed ID: 19118697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat model for anterior segment intraocular surgery induced blood-retinal barrier breakdown.
    Xie MS; Xu GX; Huang Y
    Ophthalmologica; 2008; 222(1):42-7. PubMed ID: 18097180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.